Evidence map›Paper›PMID 42751534›Full record

ArticleCureus2026

Atypical Kaposi Sarcoma in HIV Infection with Predominant Nodal Involvement.

Maria Dioselina Ruiz Barrera, Luis Ernesto Heredia Santos, Maria Alaciel Galvan Merlos, Leticia Guerrero Navarrete, Lissette Haydee García Mena, Maria Jose Hernandez Cruz, Liliana Antonio Revuelta

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria Dioselina Ruiz BarreraAdult Intensive Care Unit, Hospital Regional de Alta Especialidad de Ixtapaluca, Ixtapaluca, MEX.
Luis Ernesto Heredia SantosInternal Medicine, General Regional Hospital No. 220 "General José Vicente Villada", Instituto Mexicano del Seguro Social (IMSS), Toluca, MEX.
Maria Alaciel Galvan MerlosCritical Care Medicine, Hospital Regional de Alta Especialidad de Ixtapaluca, Ixtapaluca, MEX.
Leticia Guerrero NavarreteCritical Care Medicine, Hospital Regional de Alta Especialidad de Ixtapaluca, Ixtapaluca, MEX.
Lissette Haydee García MenaCoronary Care Unit, National Institute of Cardiology ¨Ignacio Chavez¨, Mexico City, MEX.
Maria Jose Hernandez CruzMedicine, Universidad Nacional Autónoma de México, Mexico City, MEX.
Liliana Antonio RevueltaMedicine, Instituto Politécnico Nacional, Mexico City, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kaposi sarcoma (KS) is an angioproliferative neoplasm driven by human herpesvirus 8 (HHV-8), most commonly occurring in immunocompromised individuals, particularly in association with HIV infection. Although it classically presents with characteristic cutaneous or mucocutaneous lesions, nodal-predominant disease without skin involvement is uncommon and may pose a significant diagnostic challenge. We report the case of a 26-year-old man with recently diagnosed HIV infection and no prior antiretroviral therapy (ART) who presented with a two-week history of persistent fever, constitutional symptoms, abdominal pain, and progressive intolerance to oral intake. Initial evaluation revealed hemodynamic instability, severe microcytic anemia, marked thrombocytopenia, and progressive renal dysfunction. Imaging demonstrated generalized lymphadenopathy involving multiple nodal chains, bilateral pleural effusions, hepatosplenomegaly, and free intra-abdominal fluid, raising concern for a disseminated infectious, lymphoproliferative, or neoplastic process. CD4+ T-cell count and HIV viral load were not available in the clinical records reviewed; therefore, the degree of HIV-associated immunosuppression could not be quantitatively established. Given the persistence and progression of systemic manifestations, an excisional inguinal lymph node biopsy was performed. Histopathological examination demonstrated spindle-cell proliferation with irregular slit-like vascular spaces and erythrocyte extravasation. Immunohistochemical analysis showed nuclear positivity for HHV-8 latent nuclear antigen-1 (LNA-1), together with positivity for endothelial markers, confirming KS. No cutaneous or mucosal lesions suggestive of KS were identified during the clinical course, supporting an atypical presentation with predominant nodal involvement. The patient received supportive inpatient management, including hemodynamic stabilization and transfusional support. Despite an initial period of partial clinical stabilization, he subsequently developed acute respiratory failure with progressive clinical deterioration and died during the index hospitalization before the planned HIV- and KS-directed therapeutic strategy could be completed. Nodal KS without cutaneous involvement is an uncommon and potentially underrecognized presentation that may mimic HIV-associated lymphoma, disseminated opportunistic infections, and HHV-8-associated multicentric Castleman disease. This case emphasizes that KS should remain in the differential diagnosis of persistent lymphadenopathy and systemic manifestations in patients with HIV even when characteristic skin lesions are absent. Because imaging findings are nonspecific, early tissue biopsy with histopathological examination and HHV-8 immunohistochemistry is essential for definitive diagnosis. This paper was published earlier on the Research Square preprint server on April 14, 2026 (DOI: 10.21203/rs.3.rs-9363985/v1).

Indexed as

case reportcoronavirus disease 2019 (covid-19)cutaneous hornhiv-associated malignancieshiv diseasesinguinal lymphadenopathykaposi sarcomakaposi sarcoma in immunocompetent patientopportunist infections in hivsystemic disease

Identifiers

PMID42751534
PMCPMC13580019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.